Research ArticleClinical Studies
Outcome Prediction After Neoadjuvant Chemotherapy (NAC) for Breast Cancer, Using Tumor-infiltrating Lymphocytes Within Fibrotic Foci of Tumor Stroma (FF-TILs)
SHINICHIRO KASHIWAGI, YUKA ASANO, KOJI TAKADA, WATARU GOTO, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA, KOSEI HIRAKAWA and MASAICHI OHIRA
Anticancer Research March 2022, 42 (3) 1421-1431; DOI: https://doi.org/10.21873/anticanres.15612
SHINICHIRO KASHIWAGI
1Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan;
YUKA ASANO
1Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan;
KOJI TAKADA
1Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan;
WATARU GOTO
1Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan;
TAMAMI MORISAKI
1Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan;
MASATSUNE SHIBUTANI
2Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan
HIROAKI TANAKA
2Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan
KOSEI HIRAKAWA
1Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan;
2Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan
MASAICHI OHIRA
1Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan;
2Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Outcome Prediction After Neoadjuvant Chemotherapy (NAC) for Breast Cancer, Using Tumor-infiltrating Lymphocytes Within Fibrotic Foci of Tumor Stroma (FF-TILs)
SHINICHIRO KASHIWAGI, YUKA ASANO, KOJI TAKADA, WATARU GOTO, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA, KOSEI HIRAKAWA, MASAICHI OHIRA
Anticancer Research Mar 2022, 42 (3) 1421-1431; DOI: 10.21873/anticanres.15612
Outcome Prediction After Neoadjuvant Chemotherapy (NAC) for Breast Cancer, Using Tumor-infiltrating Lymphocytes Within Fibrotic Foci of Tumor Stroma (FF-TILs)
SHINICHIRO KASHIWAGI, YUKA ASANO, KOJI TAKADA, WATARU GOTO, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA, KOSEI HIRAKAWA, MASAICHI OHIRA
Anticancer Research Mar 2022, 42 (3) 1421-1431; DOI: 10.21873/anticanres.15612
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.